Woodline Partners’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,916,167
| Closed | -$3.37M | – | 1045 |
|
|
2025
Q1 | $3.37M | Buy |
5,916,167
+5,896,873
| +30,563% | +$3.36M | 0.02% | 594 |
|
|
2024
Q4 | $27.6K | Buy |
+19,294
| New | +$27.6K | ﹤0.01% | 915 |
|
|
2024
Q3 | – | Sell |
-101,717
| Closed | -$315K | – | 702 |
|
|
2024
Q2 | $315K | Buy |
101,717
+45,717
| +82% | +$142K | ﹤0.01% | 515 |
|
|
2024
Q1 | $293K | Buy |
+56,000
| New | +$293K | ﹤0.01% | 499 |
|
|
2022
Q4 | – | Sell |
-200,698
| Closed | -$582K | – | 845 |
|
|
2022
Q3 | $582K | Hold |
200,698
| – | – | 0.01% | 584 |
|
|
2022
Q2 | $1.13M | Buy |
200,698
+163,130
| +434% | +$918K | 0.02% | 501 |
|
|
2022
Q1 | $443K | Buy |
+37,568
| New | +$443K | 0.01% | 519 |
|
|
2021
Q4 | – | Sell |
-150,080
| Closed | -$3.1M | – | 788 |
|
|
2021
Q3 | $3.1M | Buy |
+150,080
| New | +$3.1M | 0.05% | 331 |
|